High cholesterol? For most patients, that means starting a statin regimen. But now research suggests that it may be time to embrace a more nuanced approach to lowering LDL levels.

Heart attack and stroke don’t just affect patients across Europe, new research reveals.  These cardiovascular events also impact the EU’s national economies – by increasing absenteeism and reducing productivity in workplaces across the region. Productivity Loss & Economic Impact Among patients who returned to work, having a heart attack or stroke was associated with losing … Continued

As the European Union edges toward parliamentary elections, patient advocates have a message for candidates: Prioritise heart health. As outlined in a recently released manifesto from the European Heart Network, a Brussels-based alliance of foundations and associations dedicated to fighting heart disease and stroke, Members of the European Parliament have the opportunity to support investment … Continued

More than 50 percent of Europeans have raised cholesterol, increasing their risk of heart attack, stroke and death – and costing the EU billions every year in health care expenses and lost productivity.  So explains a new “Fast Facts” policy brief from the European Alliance for Patient Access, a division of the Global Alliance for … Continued

England has a plan.  It’s comprehensive, long term and aimed at preventing 150,000 heart attacks and strokes over the next 10 years.  How? By, among other measures, reducing high cholesterol, hypertension and atrial fibrillation. Recently released by the National Health Service, England’s “Long-Term Plan” outlines national health strategies for a variety of national health needs … Continued

A new international treaty has important implications for patients’ access to innovative treatments. On November 30, during the G20 Summit in Buenos Aires Argentina, President Trump, Prime Minister Trudeau and President Peña Nieto signed the new U.S. Mexico Canada Agreement. Once approved by the U.S. Congress, this trade deal will replace NAFTA as the free … Continued

Patients who are eager for the next generation of treatments and cures will be well served by the United States-Mexico-Canada Agreement.  This agreement provides intellectual property protections that promote patient access to innovative medicine, clearing the way for new treatments for cancer, Alzheimer’s, diabetes and many other conditions.